Search - tctmd.com

Displaying 241 - 260 of 955

Sort: Relevancy | Date

Visit-to-Visit BP Variability Linked to Coronary Plaque Progression, Adverse Outcomes

News Daily News

Visit-to-Visit BP Variability Linked to Coronary Plaque Progression, Adverse Outcomes

April 11, 2019

Baseline Anemia Ups Physician-Guided DAPT Discontinuation Rates After PCI

News Daily News

Baseline Anemia Ups Physician-Guided DAPT Discontinuation Rates After PCI

Yael L. Maxwell

April 10, 2019

Direct Admission to PCI-Capable Center Linked With Lower All-Cause Mortality

News Daily News

Direct Admission to PCI-Capable Center Linked With Lower All-Cause Mortality

Michael O'Riordan

March 06, 2019

Abnormal Coronary Reactivity in Women Portends Added CV, Death Risk in the Next Decade

News Daily News

Abnormal Coronary Reactivity in Women Portends Added CV, Death Risk in the Next Decade

February 13, 2019

African-American ACS Patients Less Often Treated With Prasugrel After PCI

News Daily News

African-American ACS Patients Less Often Treated With Prasugrel After PCI

Yael L. Maxwell

January 24, 2019

Femoral Operators Get Bad Rap in Observational Studies, HEAT-PPCI Suggests

News Daily News

Femoral Operators Get Bad Rap in Observational Studies, HEAT-PPCI Suggests

Michael O'Riordan

January 21, 2019

Slight Advantage for DES Over DCB for In-Stent Restenosis: Updated Meta-analysis

News Daily News

Slight Advantage for DES Over DCB for In-Stent Restenosis: Updated Meta-analysis

January 15, 2019

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Vote

News Daily News

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Review

January 11, 2019

STEMI Care and Outcomes Still Affected by Socioeconomic Status, Insurance

News Daily News

STEMI Care and Outcomes Still Affected by Socioeconomic Status, Insurance

Yael L. Maxwell

January 09, 2019

CTA an Effective Gatekeeper in Invasive Angiography Candidates With Suspected CAD

News Daily News

CTA an Effective Gatekeeper in Invasive Angiography Candidates With Suspected CAD

December 14, 2018

PIONEER 6: Oral Semaglutide Passes Test in Cardiovascular Outcomes Study

News Daily News

PIONEER 6: Oral Semaglutide Passes Test in Cardiovascular Outcomes Study

Michael O'Riordan

November 23, 2018

Debate Over BMS vs DES in High-Bleeding-Risk Scenarios Gets Fresh Fuel in Meta-analysis

News Daily News

Debate Over BMS vs DES in High-Bleeding-Risk Scenarios Gets Fresh Fuel in Meta-analysis

Yael L. Maxwell

November 05, 2018

Diabetes Drug Canagliflozin Gets MACE Reduction Indication

News Daily News

Diabetes Drug Canagliflozin Gets MACE Reduction Indication

November 01, 2018

Lingering Signs of Inflammation Post-PCI Signal More Death, MI at 1 Year

News Daily News

Lingering Signs of Inflammation Post-PCI Signal More Death, MI at 1 Year

October 31, 2018

Final Phase III Bempedoic Acid Trial Proves Positive for LDL-Lowering

News Daily News

Final Phase III Bempedoic Acid Trial Proves Positive for LDL-Lowering

October 29, 2018

Vulnerable Plaque Components Seen on IVUS Not Linked With MACE, Two New Studies Show

News Daily News

Vulnerable Plaque Components Seen on IVUS Not Linked With MACE, Two New Studies Show

Michael O'Riordan

October 17, 2018

Complete Revascularization Improves Long-term NSTEMI Outcomes, Cohort Study Suggests

News Daily News

Complete Revascularization Improves Long-term NSTEMI Outcomes, Cohort Study Suggests

October 16, 2018

Procedural Success Increasing for CTO PCI in Europe, Despite More Complex Lesions

News Daily News

Procedural Success Increasing for CTO PCI in Europe, Despite More Complex Lesions

Yael L. Maxwell

October 15, 2018

Silent Infarcts Have Similar Mortality Over 10 Years as Clinically Recognized MI

News Daily News

Silent Infarcts Have Similar Mortality Over 10 Years as Clinically Recognized MI

Yael L. Maxwell

October 10, 2018

Dapagliflozin Gets Partial Win in DECLARE-TIMI 58

News Daily News

Dapagliflozin Gets Partial Win in DECLARE-TIMI 58

October 02, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.